PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
1.50%
Net income growth under 50% of ORCL's 87.29%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
-11.11%
Negative yoy D&A while ORCL is 3.52%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
256.35%
Well above ORCL's 87.03% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
256.35%
Growth well above ORCL's 87.03%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-200.00%
Negative yoy while ORCL is 325.36%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-31.78%
Negative yoy CFO while ORCL is 76.02%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-63.95%
Both yoy lines negative, with ORCL at -2.92%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
-172.28%
Both yoy lines negative, with ORCL at -2771.40%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
No Data
No Data available this quarter, please select a different quarter.
126.69%
Less 'other investing' outflow yoy vs. ORCL's 3829.72%. David Dodd would see a stronger short-term cash position unless competitor invests more wisely.
-37.18%
Both yoy lines negative, with ORCL at -320.10%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
-111.13%
Negative yoy issuance while ORCL is 731.83%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-9488.89%
We cut yoy buybacks while ORCL is 61.94%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.